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showed average of 64.94 ± 0.84 mGy and 37.64 ± 1.20 mGy in 
left ovary part and average of 64.38 ± 1.85 mGy and 32.96 ± 
1.11 mGy in right ovary part. This showed when executing 
Tomotherapy, measured scattered dose of Tomo Helical 
method which has relatively greater monitor units (MUs) and 
longer irradiation time are approximately 1.8 times higher 
than Tomo direct method. 
Conclusions: Scattered dose of left and right ovary of 
childbearing women is lower than ICRP recommended does 
which is not seriously worried level against the infertility and 
secondary cancer occurrence. However, as breast cancer 
occurrence ages become younger in the future and radiation 
therapy using high-precision image guidance equipment like 
Tomotherapy is developed, clinical follow-up studies about 
the ovary dose of childbearing women patients would be 
more required.  
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Purpose/Objective: Radiation therapy (RT) is frequently used 
as an adjunctive treatment for soft tissue sarcoma of the 
lower limb. RT carries a risk of long term side effects 
including limb fibrosis, joint stiffness, lymphoedema and 
bone fractures. This study compared dosimetric data 
between 3DCRT and IMRT plans in a population of lower limb 
sarcoma patients immobilised with an in-house device and 
quantified the impact of systematic and random errors on 
these techniques. The dosimetric effect of translational 
displacements on target coverage and organs at risk (OARs) 
were considered. 
Materials and Methods: Eleven anonymised patients’ CT data 
were acquired. Patients had previously been treated with 
postoperative radiotherapy. A 3DCRT and IMRT plan was 
created for each patient. Total doses ranged from 60-66 Gy, 
prescribed at 2 Gy per fraction. The techniques were 
dosimetrically compared. Population-based systematic errors 
were applied to 3 fractions of each 3DCRT and IMRT plan. 
Population-based random errors were applied to 5 fractions 
of each 3DCRT and IMRT plan. The dose metrics were 
analysed and the results were compared to the initial plans. 
Results: Higher target D95, D2, D98, D50 and the best 
homogeneity index resulted with IMRT compared to 3DCRT 
(p<0.01). Maximum bone dose was higher in IMRT than 3DCRT 
(p<0.0001). Systematic errors increased target D2 in IMRT 
(p<0.05). Random errors decreased target homogeneity in 
IMRT (p<0.05), decreased mean dose to bone in both 3DCRT 
and IMRT, and decreased bone V40 in 3DCRT. Neither random 
nor systematic errors increased OAR dose for IMRT or 3DCRT 
plans.  
 
 
 
Conclusions: IMRT could become the favoured lower limb 
sarcoma radiation therapy technique due to superior target 
coverage and homogeneity. However, higher bone Dmax seen 
with IMRT compared to 3DCRT potentially increases the risk 
of late bone toxicity. Offline imaging can adequately correct 
for systematic translational errors in these patients when an 
in-house immobilisation device is used. Results would 
indicate that to maintain target homogeneity in IMRT, daily 
online imaging would be required to reduce the effects of 
random displacements as well as quantifying daily rotations. 
Rotational displacements should be simulated in further 
study, as rotations may potentially have a further dosimetric 
effect on target coverage and OARs if not corrected for.  
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Purpose/Objective: Pre-treatment verifications of IMRT 
treatments are routinely performed by measuring the 
absorbed dose at a representative point in a water-
equivalent phantom using an ionization chamber. We 
evaluated the added value of performing entrance dose in 
vivo dosimetry (IVD) using diodes in breast treatments 
delivered using a SIB-IMRT technique. 
Materials and Methods: We studied 14 breast treatments 
delivered by a Clinac 2100C/D using a 6MV photon beam SIB-
IMRT technique and the RPM system (Varian) for respiratory 
motion management. For pre-treatment verifications, we 
recorded ionization chamber measurements and treatment 
planning system calculations (Eclipse; Varian) both for per-
beam and integral dose at the measurement point. We also 
measured the time it took to perform the verifications. For 
each radiation field, the physicist selected 2 representative 
points at high and/or homogeneous fluence regions. We 
recorded the coordinates of these points and corresponding 
calculated entrance doses. Entrance dose IVD was performed 
